1. Home
  2. GRFS vs VFC Comparison

GRFS vs VFC Comparison

Compare GRFS & VFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRFS
  • VFC
  • Stock Information
  • Founded
  • GRFS 1940
  • VFC 1899
  • Country
  • GRFS Spain
  • VFC United States
  • Employees
  • GRFS N/A
  • VFC 27000
  • Industry
  • GRFS Biotechnology: Pharmaceutical Preparations
  • VFC Apparel
  • Sector
  • GRFS Health Care
  • VFC Consumer Discretionary
  • Exchange
  • GRFS Nasdaq
  • VFC Nasdaq
  • Market Cap
  • GRFS 6.6B
  • VFC 5.6B
  • IPO Year
  • GRFS 2006
  • VFC N/A
  • Fundamental
  • Price
  • GRFS $9.65
  • VFC $14.34
  • Analyst Decision
  • GRFS Hold
  • VFC Hold
  • Analyst Count
  • GRFS 1
  • VFC 18
  • Target Price
  • GRFS $10.30
  • VFC $16.69
  • AVG Volume (30 Days)
  • GRFS 522.4K
  • VFC 6.6M
  • Earning Date
  • GRFS 01-01-0001
  • VFC 10-28-2025
  • Dividend Yield
  • GRFS 1.48%
  • VFC N/A
  • EPS Growth
  • GRFS 132.60
  • VFC N/A
  • EPS
  • GRFS 0.53
  • VFC N/A
  • Revenue
  • GRFS $8,744,226,659.00
  • VFC $9,496,297,000.00
  • Revenue This Year
  • GRFS $5.46
  • VFC $1.61
  • Revenue Next Year
  • GRFS $6.69
  • VFC $2.62
  • P/E Ratio
  • GRFS $23.80
  • VFC $53.00
  • Revenue Growth
  • GRFS 9.32
  • VFC N/A
  • 52 Week Low
  • GRFS $6.19
  • VFC $9.41
  • 52 Week High
  • GRFS $11.14
  • VFC $29.02
  • Technical
  • Relative Strength Index (RSI)
  • GRFS 46.87
  • VFC 49.78
  • Support Level
  • GRFS $9.39
  • VFC $13.91
  • Resistance Level
  • GRFS $9.86
  • VFC $14.84
  • Average True Range (ATR)
  • GRFS 0.20
  • VFC 0.63
  • MACD
  • GRFS 0.00
  • VFC -0.06
  • Stochastic Oscillator
  • GRFS 41.41
  • VFC 51.17

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

About VFC V.F. Corporation

VF designs, produces, and distributes branded apparel, footwear, and accessories. Its apparel categories are active, outdoor, and work. Its portfolio of 10 brands includes Vans, The North Face, Timberland, and Altra. VF markets its products in the Americas, Europe, and Asia-Pacific through wholesale sales to retailers, e-commerce, and branded stores owned by the company and partners. Tracing its roots to 1899, the company has evolved through many brand acquisitions and dispositions.

Share on Social Networks: